Lululemon Stock Gains After Reaching Deal with Founder Chip Wilson to Resolve Proxy Fight Trade Court Ruling Invalidates Trumps 10 Blanket Tariffs AntiCorruption Messaging Faces Headwinds from Lawmaker Stock Trading Scrutiny SP 500 Edges Higher as Healthcare and Tech Lead Broad Gains Microsoft Signals Potential 190 Billion Capital Spending by 2026 Amid Rising Memory Costs Equitable Holdings Inc EQH Q1 2026 Earnings Marginal EPS Miss as Stock Edges Higher Ginkgo Bioworks DNA Q1 2026 Earnings EPS Misses Estimates Stock Gains Despite Headwinds ZIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions WaterBridge Infrastructure LLC WBI Q4 2025 Earnings Strong EPS Surprise Lifts Stock Despite Sparse Revenue Disclosure FCPT Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher TDS Shares Decline Sharply as Selling Pressure Intensifies Sabesp SBS Slips Lower as Utility Stock Tests Support Near 538 Calisa Acquisition Corp ALIS Holds Steady at 1006 Consolidating Near Key Resistance Broadridge Financial Solutions BR Holds Steady Near 147 as Consolidation Continues Nabors Industries NBR Falls 44 as Oil Service Shares Face Renewed Pressure Burke Herbert Financial Services BHRB Holds Steady Near Support Levels Amid Low Volatility Piper Sandler Warns Prolonged Strait of Hormuz Closure Could Drive Oil to Record Highs This Summer SBEV Q2 2025 Earnings EPS Misses Estimates Amid Ongoing Challenges Chinas Innovent Biologics and Pfizer Forge Potential 105 Billion Drug Collaboration Spains Youth Housing Crisis Renting Alone Now Costs 987 of Average Wage TSLA Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Jaguar JAGX Idles at 320 Time to Be Patient or Worried 20260528 Annovis Bio Q1 2026 Earnings EPS Misses Estimates as PreClinical Spending Intensifies Stantec Inc STN Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution CRS Q1 2026 Earnings EPS Beat Driven by Strong Demand in Aerospace and Defense TCMD Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares TPCS Q1 2026 Earnings Net Loss of 015 Per Share as Revenue Details Remain Unavailable IMRX Q1 2026 Earnings EPS Beat Estimates by 183 as Clinical Pipeline Advances SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development